412 related articles for article (PubMed ID: 27969575)
21. Development and pilot testing of a Decision Aid (DA) for women with early-stage breast cancer considering contralateral prophylactic mastectomy.
Ager B; Jansen J; Porter D; Phillips KA; Glassey R; ; Butow P
Breast; 2018 Aug; 40():156-164. PubMed ID: 29857282
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).
Davies KR; Brewster AM; Bedrosian I; Parker PA; Crosby MA; Peterson SK; Shen Y; Volk RJ; Cantor SB
Breast Cancer Res; 2016 Sep; 18(1):93. PubMed ID: 27650678
[TBL] [Abstract][Full Text] [Related]
23. Redefining Risk and Benefit: Understanding the Decision to Undergo Contralateral Prophylactic Mastectomy.
Rendle KA; Halley MC; May SG; Frosch DL
Qual Health Res; 2015 Sep; 25(9):1251-9. PubMed ID: 25371380
[TBL] [Abstract][Full Text] [Related]
24. Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
Murphy BL; Hoskin TL; Boughey JC; Degnim AC; Glazebrook KN; Hieken TJ
Ann Surg Oncol; 2016 Oct; 23(10):3365-70. PubMed ID: 27364506
[TBL] [Abstract][Full Text] [Related]
25. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
[TBL] [Abstract][Full Text] [Related]
26. Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.
Parker PA; Peterson SK; Bedrosian I; Crosby MA; Shen Y; Black DM; Babiera G; Kuerer HM; Ying J; Dong W; Cantor SB; Brewster AM
Ann Surg; 2016 Jan; 263(1):178-83. PubMed ID: 25822675
[TBL] [Abstract][Full Text] [Related]
27. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
[TBL] [Abstract][Full Text] [Related]
28. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.
Rosenberg SM; Tracy MS; Meyer ME; Sepucha K; Gelber S; Hirshfield-Bartek J; Troyan S; Morrow M; Schapira L; Come SE; Winer EP; Partridge AH
Ann Intern Med; 2013 Sep; 159(6):373-81. PubMed ID: 24042365
[TBL] [Abstract][Full Text] [Related]
29. Practitioner Opinion on Contralateral Prophylactic Mastectomy: How Do We Steer a Patient-Driven Discussion?
Schellenberg AE; Stypulkowski A; Cordeiro E; Holloway CMB; Eisen A; Scheer AS
Ann Surg Oncol; 2019 Oct; 26(11):3489-3494. PubMed ID: 31187367
[TBL] [Abstract][Full Text] [Related]
30. Contralateral prophylactic mastectomy for unilateral breast cancer in women at average risk: Systematic review of patient reported outcomes.
Srethbhakdi A; Brennan ME; Hamid G; Flitcroft K
Psychooncology; 2020 Jun; 29(6):960-973. PubMed ID: 32201988
[TBL] [Abstract][Full Text] [Related]
31. Surgical Decision-Making Surrounding Contralateral Prophylactic Mastectomy: Comparison of Treatment Goals, Preferences, and Psychosocial Outcomes from a Multicenter Survey of Breast Cancer Patients.
Lizarraga IM; Schroeder MC; Jatoi I; Sugg SL; Trentham-Dietz A; Hoeth L; Chrischilles EA
Ann Surg Oncol; 2021 Dec; 28(13):8752-8765. PubMed ID: 34251554
[TBL] [Abstract][Full Text] [Related]
32. Contralateral prophylactic mastectomy: A qualitative approach to exploring the decision making process.
Greener JR; Bass SB; Lepore SJ
J Psychosoc Oncol; 2018; 36(2):145-158. PubMed ID: 29064771
[TBL] [Abstract][Full Text] [Related]
33. Streamlining Decision Making in Contralateral Risk-Reducing Mastectomy: Impact of PREDICT and BOADICEA Computations.
de Silva TS; Russell VR; Henry FP; Thiruchelvam PTR; Hadjiminas DJ; Al-Mufti R; Hogben RK; Hunter J; Wood S; Jallali N; Leff DR
Ann Surg Oncol; 2018 Oct; 25(10):3057-3063. PubMed ID: 30019305
[TBL] [Abstract][Full Text] [Related]
34. Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.
van Sprundel TC; Schmidt MK; Rookus MA; Brohet R; van Asperen CJ; Rutgers EJ; Van't Veer LJ; Tollenaar RA
Br J Cancer; 2005 Aug; 93(3):287-92. PubMed ID: 16052221
[TBL] [Abstract][Full Text] [Related]
35. Operating on Anxiety: Negative Affect toward Breast Cancer and Choosing Contralateral Prophylactic Mastectomy.
Silverstein MC; Lee CN; Scherer LD; Phommasathit C; Merrill AL; Peters E
Med Decis Making; 2023 Feb; 43(2):152-163. PubMed ID: 36059240
[TBL] [Abstract][Full Text] [Related]
36. Contralateral prophylactic mastectomy (CPM): A systematic review of patient reported factors and psychological predictors influencing choice and satisfaction.
Ager B; Butow P; Jansen J; Phillips KA; Porter D;
Breast; 2016 Aug; 28():107-20. PubMed ID: 27290619
[TBL] [Abstract][Full Text] [Related]
37. My mind is made up: Cancer concern and women's preferences for contralateral prophylactic mastectomy.
De Abreu Lourenço R; Haas M; Hall J; Parish K; Stuart D; Viney R
Eur J Cancer Care (Engl); 2019 Jul; 28(4):e13058. PubMed ID: 31006930
[TBL] [Abstract][Full Text] [Related]
38. Issues of regret in women with contralateral prophylactic mastectomies.
Montgomery LL; Tran KN; Heelan MC; Van Zee KJ; Massie MJ; Payne DK; Borgen PI
Ann Surg Oncol; 1999 Sep; 6(6):546-52. PubMed ID: 10493622
[TBL] [Abstract][Full Text] [Related]
39. Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
Hawley ST; Jagsi R; Morrow M; Janz NK; Hamilton A; Graff JJ; Katz SJ
JAMA Surg; 2014 Jun; 149(6):582-9. PubMed ID: 24849045
[TBL] [Abstract][Full Text] [Related]
40. Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.
Tynan M; Peshkin BN; Isaacs C; Willey S; Valdimarsdottir HB; Nusbaum R; Hooker G; O'Neill SC; Jandorf L; Kelly SP; Heinzmann J; Kelleher S; Poggi E; Schwartz MD
Breast Cancer Res Treat; 2020 Feb; 180(1):177-185. PubMed ID: 31894446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
